ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,000 | -81.0% | 13,512 | -72.0% | 0.00% | – |
| Q4 2021 | $105,000 | -45.9% | 48,245 | -11.5% | 0.00% | – |
| Q3 2021 | $194,000 | -71.4% | 54,530 | -53.9% | 0.00% | -100.0% |
| Q2 2021 | $679,000 | +165.2% | 118,337 | +139.7% | 0.00% | – |
| Q1 2021 | $256,000 | +232.5% | 49,368 | +44.6% | 0.00% | – |
| Q4 2019 | $77,000 | -47.6% | 34,140 | -51.1% | 0.00% | – |
| Q3 2019 | $147,000 | – | 69,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |